BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32088338)

  • 1. HIV drug resistance early warning indicators in Ethiopia: Variability at regional and health facility levels and trend over time.
    Getaneh Y; Zealyas K; Adugna F; Kursha K; Atsbeha G/Egziabxier ; Kassa D; Assefa Y
    Int J Infect Dis; 2020 Jun; 95():90-97. PubMed ID: 32088338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early warning indicators for HIV drug resistance in Cameroon during the year 2010.
    Billong SC; Fokam J; Nkwescheu AS; Kembou E; Milenge P; Tsomo Z; Dion GN; Aghokeng AF; Mpoudi EN; Ndumbe PM; Colizzi V; Elat Nfetam JB
    PLoS One; 2012; 7(5):e36777. PubMed ID: 22615810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV drug-resistance early-warning indicators and quality care in India: preliminary findings from a pilot study in Pune city.
    Ghate M; Kadam D; Gaikwad N; Shankar S; Gurav S; Rahane G; Tanwar S; Rewari B; Gangakhedkar R
    WHO South East Asia J Public Health; 2015; 4(2):123-129. PubMed ID: 28607310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.
    Asio J; Watera C; Namuwenge N; Kirungi W; Musinguzi J; Mugagga K; Busobozi R; Tusiime BJ; Lutalo T; Mbidde EK; Kaleebu P;
    PLoS One; 2020; 15(4):e0230451. PubMed ID: 32287264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.
    Fokam J; Billong SC; Bissek AC; Kembou E; Milenge P; Abessouguie I; Nkwescheu AS; Tsomo Z; Aghokeng AF; Ngute GD; Ndumbe PM; Colizzi V; Elat JB
    BMC Public Health; 2013 Apr; 13():308. PubMed ID: 23565992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.
    Jonas A; Sumbi V; Mwinga S; DeKlerk M; Tjituka F; Penney S; Jordan MR; Desta T; Tang AM; Hong SY
    PLoS One; 2014; 9(7):e100539. PubMed ID: 24988387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early warning indicators for HIV drug resistance in adults in South Africa at 2 pilot sites, 2008-2010.
    Dube NM; Tint KS; Summers RS
    Clin Infect Dis; 2014 Jun; 58(11):1607-14. PubMed ID: 24585566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [National profile of early warning indicators of HIV pharmaco-resistance in Cameroon].
    Billong SC; Fokam J; Penda CI; Mvilongo EA; Fodjo R; Messeh A; Anoubissie JD; Kegne C; Nguekam G; Batamack YA; Billong EJ; Moutapam PR; Ndjolo A; Bonono L; Elat JB; Bissek ACZ
    Pan Afr Med J; 2020; 37():374. PubMed ID: 33796187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya.
    Pilgrim NA; Okal J; Matheka J; Mukui I; Kalibala S
    BMC Pediatr; 2018 Jul; 18(1):243. PubMed ID: 30045700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring HIV Drug Resistance: Early Warning Indicators to Assess Performance of Thailand's Antiretroviral Treatment Program.
    Lertpiriyasuwat C; Teeraratkul A; Suchonwanich Y; Chatharojwong N; Phokasawad K; Yuktanon P; Pattarapayoon N; Bhakeecheep S; Bertagnolio S; Roels TH; Thanprasertsuk S
    J Med Assoc Thai; 2017 Sep; 100(9):944-952. PubMed ID: 29861515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania.
    Juma JM; Tiberio JK; Abuya MI; Kilama BK; Somi GR; Sambu V; Banda R; Jullu BS; Ramadhani AA
    BMC Infect Dis; 2014 Apr; 14():196. PubMed ID: 24725750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.
    St-Jean M; Harrigan PR; Sereda P; Montaner J; Lima VD
    HIV Med; 2017 May; 18(5):342-353. PubMed ID: 27704659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of implementing an integrated tool for improvement of treatment quality and early-warning indicators for HIV drug resistance: a pilot study of centres in India.
    Rewari BB; Seguy NS; Tanwar SS; Chan PL; Purohit V; Harvey P; Yu D; Rathore AS
    WHO South East Asia J Public Health; 2015; 4(2):184-188. PubMed ID: 28607317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early warning indicators of HIV drug resistance in the southern highlands region of Tanzania: Lessons from a cross-sectional surveillance study.
    Khamadi SA; Mavere C; Bahemana E; Lwilla A; Mizinduko M; Bwigane S; Peter A; Makando J; Peter B; Agaba P; Shah N; Julu B; Ganesan K; Coakley P; Lee EH
    PLOS Glob Public Health; 2023; 3(3):e0000929. PubMed ID: 36996096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supply Chain Management Performance of HIV/AIDS Commodities and Factors Affecting It at Health Facilities of SNNPRS of Ethiopia; from the Perspective of Achieving 90-90-90 Strategies.
    Damtie TA; Ibrahim AJ; Yikna BB
    Integr Pharm Res Pract; 2020; 9():11-21. PubMed ID: 32021834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.
    Mutenda N; Bukowski A; Nitschke AM; Nakanyala T; Hamunime N; Mekonen T; Tjituka F; Mazibuko G; Mwinga S; Mabirizi D; Sagwa E; Indongo R; Dean N; Jordan MR; Hong SY
    PLoS One; 2016; 11(12):e0166649. PubMed ID: 27906995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations.
    Fokam J; Elat JB; Billong SC; Kembou E; Nkwescheu AS; Obam NM; Essiane A; Torimiro JN; Ekanmian GK; Ndjolo A; Shiro KS; Bissek AC
    PLoS One; 2015; 10(6):e0129210. PubMed ID: 26083364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV drug resistance early warning indicators in Namibia for public health action.
    Jonas A; Gweshe J; Siboleka M; Deklerk M; Gawanab M; Badi A; Sumbi V; Pereko D; Blom A; Mwinga S; Jordan MR; Jerger L; Lau K; Hong SY
    PLoS One; 2013; 8(6):e65653. PubMed ID: 23762406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
    Sigaloff KC; Hamers RL; Menke J; Labib M; Siwale M; Ive P; Botes ME; Kityo C; Mandaliya K; Wellington M; Osibogun A; Geskus RB; Stevens WS; van Vugt M; Rinke de Wit TF;
    Clin Infect Dis; 2012 May; 54 Suppl 4():S294-9. PubMed ID: 22544190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention in Care of Adult HIV Patients Initiating Antiretroviral Therapy in Tigray, Ethiopia: A Prospective Observational Cohort Study.
    Bucciardini R; Fragola V; Abegaz T; Lucattini S; Halifom A; Tadesse E; Berhe M; Pugliese K; Binelli A; De Castro P; Terlizzi R; Fucili L; Di Gregorio M; Mirra M; Olivieri E; Teklu T; Zegeye T; Haile A; Vella S; Abraham L; Godefay H;
    PLoS One; 2015; 10(9):e0136117. PubMed ID: 26340271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.